Cyclacel Pharmaceuticals, Inc. announces private placement of 7,956 shares of common stock at an issue price of $3.315 per share and warrants to purchase up to 7,956 shares of common stock with an exercise price of $3.19 per share to members of management for gross proceeds of $26,374.14 on December 22, 2023. The transaction is expected to close on December 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 USD | -4.71% |
|
-7.43% | -39.33% |
26/06 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
26/06 | Sector Update: Health Care Stocks Lower in Afternoon Trading | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.33% | 2.37M | |
+15.20% | 121B | |
+19.67% | 113B | |
+16.94% | 26.02B | |
-23.86% | 19.39B | |
-19.49% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $0.026374 million in funding